Sb Investment Advisers (Uk) LTD Roivant Sciences Ltd. Transaction History
Sb Investment Advisers (Uk) LTD
- $11.4 Billion
- Q4 2024
A detailed history of Sb Investment Advisers (Uk) LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 62,057,537 shares of ROIV stock, worth $666 Million. This represents 6.45% of its overall portfolio holdings.
Number of Shares
62,057,537
Previous 65,934,074
5.88%
Holding current value
$666 Million
Previous $761 Million
3.51%
% of portfolio
6.45%
Previous 6.27%
Shares
7 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$707 Million76.3% of portfolio
-
Viking Global Investors LP47.8MShares$513 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$473 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$380 Million0.01% of portfolio
-
Morgan Stanley New York, NY34.6MShares$372 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.57B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...